Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • The significance of non-motor microtubule-associated protein in maintaining synaptic plasticity thorough a novel mechanism

  • Parental preference for boys damages girls? self-esteem and happiness

  • Scientists discover molecular link between psychiatric disorders and type 2 diabetes

  • Head injury patients develop brain clumps associated with Alzheimer?s disease

  • Neurobiological changes explain how mindfulness meditation improves health

  • Athlete passion linked to acceptance of performance enhancing drugs

  • Mesh-like scaffold is disordered in Alzheimer's-affected cells

  • Gambling is associated with 'risk-taking behavior' in young teens, study finds

  • Researchers home in on why female newborns are better protected from brain injury

  • Better quality of care may reduce risk of death for patients on opioid painkillers

  •